Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations

por Muñoz-Guglielmetti, Diego, Sanchez-Lorente, David, Reyes, Roxana, Martinez, Daniel, Lucena, Carmen, Boada, Marc, Paredes, Pilar, Parera-Roig, Marta, Vollmer, Ivan, Mases, Joel, Martin-Deleon, Roberto, Castillo, Sergi, Benegas, Mariana, Muñoz, Silvia, Mayoral, Maria, Cases, Carla, Mollà, Meritxell, Casas, Francesc
Publicado 2021